MAPT and Alzheimer disease: Interestingly, we did not detect a relationship between testosterone and AD biomarkers, including CSF Aβ and tau, even though previous studies found androgen levels inversely correlated with plasma Aβ (Gillett et al., 2003), and brain amyloid levels as measured by PiB retention in MCI patients (Verdile et al., 2014).